CJC-1295-+-IPAMORELIN-10MG

Description

CJC-1295 / IPA is a multi-component research peptide blend containing CJC-1295 and Ipamorelin, supplied for controlled laboratory, analytical, and scientific research.

Because the blend contains two chemically distinct peptide materials, the complete formulation does not have one universal CAS number, molecular formula, molecular weight, or amino-acid sequence. Each component should be documented separately.

The abbreviation IPA in this product name refers to Ipamorelin. An important technical distinction is that CJC-1295 may be supplied as either CJC-1295 With DAC or CJC-1295 No DAC / Modified GRF (1-29). The exact form used in the blend should be confirmed from the product label and Certificate of Analysis.

Component 1 — CJC-1295

If CJC-1295 No DAC

Alternative Name: Modified GRF (1-29)
Common CAS Reference: 863288-34-0
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: Approximately 3367.9 g/mol
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Length: 29 amino acid residues

If CJC-1295 With DAC

CAS #: 446262-90-4
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: Approximately 3647.2 g/mol
Product Type: DAC-Modified Synthetic Research Peptide

The DAC modification forms part of the complete molecular identity and should be retained in technical documentation.

Component 2 — Ipamorelin

CAS #: 170851-70-4
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: Approximately 711.85 g/mol
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Length: 5 residues
Product Type: Modified Synthetic Research Pentapeptide

Ipamorelin contains non-standard and D-configured amino acid residues, along with C-terminal amidation, all of which are part of its complete molecular identity.

Research Applications

CJC-1295 / IPA may be examined in controlled non-clinical research involving:

• Multi-peptide analytical characterization
• Component identity verification
• Ligand-receptor interaction studies
• Molecular signaling research
• Structure-function analysis
• Comparative peptide analysis
• Blend stability assessment
• Non-clinical biochemical and cellular models

Experimental observations should remain specific to the applicable research system and should not be interpreted as evidence of hormonal benefit, performance enhancement, therapeutic effectiveness, or clinical suitability.

Analytical Identification

Relevant analytical characterization may include:

• CJC-1295 form confirmation
• DAC or No-DAC verification
• Ipamorelin identity confirmation
• Component-ratio verification
• Molecular-mass assessment
• Chromatographic purity testing
• Modified-residue characterization
• Terminal-modification verification
• Lot-specific quality analysis

Specifications & Documentation

Lot-specific documentation should be reviewed for:

• Exact CJC-1295 form
• Ipamorelin identity
• Amount of each component
• Blend ratio
• Individual CAS numbers
• Individual molecular formulas
• Individual molecular weights
• Peptide sequences or structural definitions
• DAC status
• Terminal modifications
• Salt or counter-ion forms
• Purity specifications
• Analytical testing
• Lot or batch information
• Certificate of Analysis
• Storage requirements

Authenticated product-specific documentation should take precedence over generalized blend specifications.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Follow established laboratory procedures appropriate for multi-component research peptide materials.

Research Use Only

CJC-1295 / IPA is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, hormonal use, performance enhancement, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, hormonal, performance-related, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.